Treatment of Essential Tremor
Propranolol (80-240 mg/day) or primidone should be initiated as first-line treatment for essential tremor when symptoms interfere with function or quality of life, with both medications effective in up to 70% of patients. 1
First-Line Pharmacological Treatment
The American Academy of Neurology establishes propranolol and primidone as the two evidence-based first-line options for essential tremor 1. These medications have been used for over 40 years with demonstrated efficacy 1.
Key treatment principles:
- Only initiate medication when tremor interferes with function or quality of life 1
- Both propranolol and primidone reduce tremor severity by approximately 50% in responsive patients 2, 3
- If one agent fails, the other should be tried before moving to second-line options 1
- The two medications can be combined if monotherapy provides inadequate control 2
Propranolol Dosing and Mechanism
- Dosage range: 80-240 mg/day 1
- Works by blocking peripheral effects of adrenaline and modulating noradrenergic GABA outflow centrally 4
- Decreases corticospinal excitability and increases short afferent inhibition 4
Primidone Considerations
- Has intrinsic anti-tremor properties independent of its phenobarbital metabolite 1
- Clinical benefits may not appear for 2-3 months, requiring an adequate trial period 1
- Modulates GABA-A and GABA-B intracortical circuits and blocks voltage-gated sodium channels 4
- Better baseline cerebellar function (measured by eyeblink classical conditioning) predicts better response 4
Important Contraindications and Precautions
Beta-blockers like propranolol must be avoided in patients with: 1, 5
- Chronic obstructive pulmonary disease or asthma
- Bradycardia or heart block
- Congestive heart failure
Common adverse effects of beta-blockers include: 1
- Fatigue and depression
- Dizziness and hypotension
- Exercise intolerance and sleep disorders
- Cold extremities and bronchospasm
Primidone-specific concerns: 1
- Behavioral disturbances, irritability, and sleep disturbances at higher doses
- Teratogenic risks (neural tube defects) - counsel women of childbearing age
Clinical pearl: For patients with both essential tremor and hypertension, propranolol provides dual therapeutic benefits 1, 5
Second-Line Pharmacological Options
If first-line agents fail or are contraindicated, consider: 1, 2
- Carbamazepine - generally less effective than first-line therapies
- Gabapentin - limited evidence for moderate efficacy
- Topiramate - may provide benefit in selected cases 6
- Benzodiazepines (clonazepam) - can be helpful, particularly for stress-induced tremor 2
Alternative Beta-Blockers
If propranolol causes adverse effects, other beta-blockers may be tried, though they are generally less effective: 1, 2
- Nadolol: 40-320 mg daily
- Metoprolol: 25-100 mg extended release daily or twice daily
- Atenolol: limited evidence for moderate effect
- Timolol: 20-30 mg/day
Surgical Interventions for Medication-Refractory Tremor
Surgical therapies should be considered when medications fail due to lack of efficacy at maximum doses, dose-limiting side effects, or medical contraindications. 1
Treatment Algorithm for Surgical Candidates
For unilateral tremor or patients with medical comorbidities:
- Magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy is preferred 1
- Shows sustained tremor improvement of 56% at 4 years 1
- Lowest complication rate: 4.4% compared to radiofrequency thalamotomy (11.8%) and DBS (21.1%) 1, 5
- Early adverse effects include gait disturbance (36%) and paresthesias (38%), decreasing to 9% and 14% by 1 year 1
- Serious adverse events are rare (1.6%) 1
MRgFUS contraindications: 1, 5
- Cannot undergo MRI
- Skull density ratio <0.40
- Bilateral treatment needed
- Previous contralateral thalamotomy
For bilateral tremor or MRgFUS contraindications:
- Deep brain stimulation (DBS) of the ventral intermediate nucleus (VIM) of the thalamus 1, 6
- Provides adjustable, reversible tremor control that can be optimized over time 1
- Approximately 90% tremor control rate 2
- Preferred for younger patients as it offers long-term adjustability 1
Radiofrequency thalamotomy:
- Available but carries higher complication risks than MRgFUS 1
- Reserved for cases where DBS and MRgFUS are not feasible 1
Common Pitfalls to Avoid
- Do not prescribe beta-blockers without screening for contraindications - particularly important in elderly patients with cardiac or pulmonary comorbidities 7, 1
- Do not abandon primidone prematurely - allow 2-3 months for clinical benefit to manifest 1
- Do not use aspirin or other inadequate treatments - propranolol and primidone are the only evidence-based first-line options 1
- Do not delay surgical referral in severely disabled patients - surgical options provide superior tremor control (approximately 90%) compared to medications (approximately 50%) 2, 3
- Regular assessment of tremor severity and medication side effects is essential - dose adjustments may be needed based on clinical response and tolerability 1